Renibus Therapeutics, Inc.

ACTIVE

181 Grand Ave Ste 225, Southlake, Texas, United Stateswww.renibus.comHolding11–50 employeesEstablished: 2016-01-01

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2016

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

40.0%

Phase 2

20.0%

Phase 3

20.0%

Trial Status Distribution

Active, not recruiting

10.0%

Completed

50.0%

Recruiting

10.0%

Terminated

20.0%

Withdrawn

10.0%

Clinical Trials

Trials sponsored by this organization (10)

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

Phase 3

Recruiting

interventional

Jan 2026150 participants

Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery

Active, not recruiting

observational

Nov 2023200 participants

Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery

Phase 3

Completed

interventional

Oct 2023454 participants

An Evaluation of Patient Reported Outcomes and Clinical Outcomes

Terminated

observational

Oct 2023353 participants

Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery

Phase 2

Completed

interventional

Aug 2021152 participants

A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)

Phase 2

Terminated

interventional

Aug 202042 participants

A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease

Phase 1

Completed

interventional

Aug 201954 participants

A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease

Phase 1

Completed

interventional

Mar 201942 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations